AKT1 and breast carcinoma: In breast cancer cells, diosgenin, a traditional Chinese medicine monomer, has been proven to inhibit Akt and mTOR phosphorylation while enhancing JNK phosphorylation, leading to the inhibition of cell proliferation and the induction of apoptosis [48].